The Latest Breaking News on Pharma

Investors don't fully appreciate Gilead Sciences' leadership in HIV treatment, an analyst said Friday as he upgraded GILD stock.

Catalyst Pharmaceuticals (CPRX) delivered a robust performance in its last reported quarter. So, is now the right entry point in the stock? Let’s look at its financial metrics to gauge its prospects.

Previously the Ministry of AYUSH signed an MoU with ASCI for two years to undertake monitoring of AYUSH-related advertisements.

The public notice issued by the apex drug controller on its website said: “The impugned product may be unsafe and its use may result in adverse reaction.”

With the rising prevalence of chronic diseases, the demand for pharmaceutical products is anticipated to rise. Therefore, investors could consider buying three fundamentally robust pharma stocks, Eli Lilly and Company (LLY), Zoetis (ZTS), and Taro Pharmaceutical Industries (TARO), which are gaining traction among institutional investors this month. Learn more….

The Essure device reportedly left many women suffering ‘excrutiating pain’ and other symptoms

Biotech stock Insmed rocketed Tuesday after the company said almost 44% of lung infection patients improved after receiving its drug.

‘I was in pain pretty much every day. And then I started having periods that lasted 28-30 days at a time,’ woman says

Group claim able to proceed against maker Bayer after women said implant caused pain, BBC reports